VENROCK MANAGEMENT III LLC

CIK 00012392477 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001239247

Recent Transactions

50 trades

Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−142,607→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+15,446→ 47,077 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+214,820→ 214,820 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−25,233→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−41,270→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−227,117→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−3,563→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+9,285→ 284,735 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+48,333→ 48,333 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+41,270→ 1,265,504 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+227,117→ 275,450 total
Conversion
Vitae Pharmaceuticals, Inc
Series B Preferred Stock
2014-09-29−1,009,414→ 0 total
Conversion
Vitae Pharmaceuticals, Inc
Series A-2 Preferred Stock
2014-09-29−32,086→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+139,019→ 423,754 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,009,414→ 1,224,234 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+1,031→ 31,631 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+5,367→ 5,367 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−9,285→ 0 total
Purchase
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29$8.00/sh+617,868→ 1,883,372 total
Conversion
Vitae Pharmaceuticals, Inc
Common Stock
2014-09-29+25,233→ 30,600 total
Conversion
Vitae Pharmaceuticals, Inc
Series C Preferred Stock
2014-09-29−1,031→ 0 total
Sale
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-11-20$24.96/sh−14,000→ 2,341,417 total
Other
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-11-19−686,000→ 2,351,584 total
Other
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-11-19+3,833→ 2,355,417 total
Sale
VOCERA COMMUNICATIONS, INC.
Put Option (obligation to buy)
2012-04-02−174,981→ 174,981 total
Conversion
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02+222,317→ 2,862,604 total
Conversion
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02+2,105,262→ 2,105,262 total
Conversion
VOCERA COMMUNICATIONS, INC.
Series C Convertible Preferred Stock
2012-04-02−2,105,262→ 0 total
Exercise of In-Money
VOCERA COMMUNICATIONS, INC.
Stock Option (right to buy)
2012-04-02+19,240→ 19,240 total
Exercise of In-Money
VOCERA COMMUNICATIONS, INC.
Stock Option (right to buy)
2012-04-02+25,562→ 25,562 total
Conversion
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02+113,811→ 2,640,287 total
Conversion
VOCERA COMMUNICATIONS, INC.
Series E Convertible Preferred Stock
2012-04-02−113,811→ 0 total
Conversion
VOCERA COMMUNICATIONS, INC.
Common Stock Purchase Warrant (right to buy)
2012-04-02+34,142→ 34,142 total
Exercise of In-Money
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02$17.78/sh+130,179→ 2,992,783 total
Conversion
VOCERA COMMUNICATIONS, INC.
Series D Convertible Preferred Stock
2012-04-02−421,214→ 0 total
Conversion
VOCERA COMMUNICATIONS, INC.
Series F Convertible Preferred Stock
2012-04-02−222,317→ 0 total
Conversion
VOCERA COMMUNICATIONS, INC.
Series E Convertible Pref St Purchase Warrant (right to buy)
2012-04-02−34,142→ 0 total
Conversion
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02+421,214→ 2,526,476 total
Purchase
VOCERA COMMUNICATIONS, INC.
Call Option (right to buy)
2012-04-02+1→ 1 total
Exercise of In-Money
VOCERA COMMUNICATIONS, INC.
Put Option (obligation to buy)
2012-04-02−174,981→ 0 total
Exercise of In-Money
VOCERA COMMUNICATIONS, INC.
Common Stock
2012-04-02$17.78/sh+174,980→ 3,037,584 total
Conversion
IMPERVA INC
Series C Convertible Preferred Stock
2011-11-15−471,835→ 0 total
Conversion
IMPERVA INC
Series B Convertible Preferred Stock
2011-11-15−1,314,000→ 0 total
Conversion
IMPERVA INC
Common Stock
2011-11-15+192,790→ 2,131,994 total
Conversion
IMPERVA INC
Common Stock
2011-11-15+471,835→ 1,939,204 total
Conversion
IMPERVA INC
Common Stock
2011-11-15+1,314,000→ 1,467,369 total
Conversion
IMPERVA INC
Series D Convertible Preferred Stock
2011-11-15−192,790→ 0 total
Purchase
IMPERVA INC
Common Stock
2011-11-09$18.00/sh+153,369→ 153,369 total
Purchase
SIRNA THERAPEUTICS INC
Warrants (right to buy)
2005-07-06+360,000→ 360,000 total
Purchase
SIRNA THERAPEUTICS INC
Common Stock
2005-07-06$1.60/sh+1,000,000→ 6,038,805 total

Companies

Recent Filings

4
Vitae Pharmaceuticals, Inc
Oct 1, 2014

Address

530 FIFTH AVENUE 22ND FLOOR

NEW YORK, NY, 10036

View on SEC.gov